LM-102 / LaNova Medicines Limited 
Welcome,         Profile    Billing    Logout  
  Diseases    Trials    Trials    News 
1 Trials

   

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
LM-102 / LaNova Medicines Limited
NCT05008445: Study of LM-102 in Patients With Advance Solid Tumors

Terminated
1/2
11
RoW
LM-102 Injection, LM-102 Injection combined with SOC
LaNova Medicines Development Co., Ltd., Shanghai Zhongshan Hospital, First Affiliated Hospital of Harbin Medical University, First Affiliated Hospital of Zhejiang University, Sir Run Run Shaw Hospital
Advanced Solid Tumor
02/23
02/23

Download Options